Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05373043 · ClinicalTrials.gov registry record · NA

Long-term COVID and Rehabilitation

A NA study of Long COVID, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT05373043 is a NA study of Long COVID that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 300 participants, below the 2,182-participant average among 50 other Long COVID trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05373043, a NA study of Long COVID, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19. The investigators expected outcomes will have an important positive impact because they will provide scientifically sound recommendations for rehabilitation to improve vascular endothelial function and minimize the long-term consequences of COVID-19.

Conditions Studied

Long COVID

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Mitoquinone

Study Locations (1)

Utah

  • VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-11-01
Est. Completion 2028-10-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05373043

The ClinicalTrials.gov registry entry for NCT05373043 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,182-participant average among 50 other Long COVID trials with a reported enrollment target (86% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05373043 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05373043 about?

NCT05373043 is a clinical study titled "Long-term COVID and Rehabilitation". The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19...

What is the current status of trial NCT05373043?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-11-01. Estimated completion is 2028-10-31.

What conditions does trial NCT05373043 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT05373043?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Mitoquinone (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05373043?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05373043 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.